C C Ho Selected Research

C C Ho Research Topics

2	Neoplasms (Cancer) 06/2003 - 01/2000
1	Breast Diseases (Breast Disease) 05/2009
1	Breast Neoplasms (Breast Cancer) 05/2009
1	Hypersensitivity (Allergy) 03/2007
1	Necrosis 01/2005
1	Infections 01/2005
1	Lung Neoplasms (Lung Cancer) 06/2003
1	Lymphangioma (Cavernous Lymphangioma) 12/2001
1	Hemangiosarcoma (Angiosarcoma) 12/2001
1	Pain (Aches) 12/2001
1	Hemangioma (Angioma) 12/2001
1	Herpes Zoster 12/2001
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2001
1	Hydronephrosis 01/2001
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2000
1	Transitional Cell Carcinoma 01/2000
1	Carcinogenesis 01/2000
1	Hepatocellular Carcinoma (Hepatoma) 01/2000
1	Leukemia 01/2000

2	DNA (Deoxyribonucleic Acid)IBA 06/2003 - 01/2000
2	AcetyltransferasesIBA 06/2003 - 01/2000
2	2-aminofluoreneIBA 06/2003 - 01/2000
2	Messenger RNA (mRNA)IBA 06/2003 - 12/2001
2	DNA AdductsIBA 06/2003 - 01/2000
2	N-acetyltalosaminuronic acid (NAT)IBA 11/2000 - 01/2000
1	Hormones (Hormone)IBA 05/2009
1	Testosterone (Sustanon)FDA Link 05/2009
1	Gonadal Steroid Hormones (Sex Hormones)IBA 05/2009
1	Estradiol (Delestrogen)FDA LinkGeneric 05/2009
1	Progesterone FDA LinkGeneric 05/2009
1	Pharmaceutical PreparationsIBA 03/2007
1	Annexin A5IBA 01/2005
1	Viral AntigensIBA 01/2005
1	Caspase 3 (Caspase-3)IBA 01/2005
1	CurcuminIBA 06/2003
1	NucleotidesIBA 06/2003
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2001
1	Vascular Endothelial Growth Factor CIBA 12/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2001
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 12/2001
1	RNA (Ribonucleic Acid)IBA 12/2001
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2001
1	Radioisotopes (Radionuclides)IBA 01/2001
1	Arylamine N-AcetyltransferaseIBA 01/2000
1	Antineoplastic Agents (Antineoplastics)IBA 01/2000
1	Proteins (Proteins, Gene)FDA Link 01/2000
1	2-aminofluorene-DNA complexIBA 01/2000
1	Keratin-18 (Keratin 18)IBA 01/2000
1	BerberineIBA 01/2000

1	Therapeutics 12/2001